Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05207670
Title A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies (MorningSun)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Genentech, Inc.
Indications

mantle cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

marginal zone B-cell lymphoma

B-cell lymphoma

Therapies

Mosunetuzumab + Tocilizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.